Article Sidebar

PDF
Date Published: 10/11/2021
Abstract Views: 83
Views PDF: 68
DOI: https://doi.org/10.60117/vjmap.v1iDacbiet.188
Issue
Vol. 1 No. Dacbiet (2021)
Section
Research Articles
How to Cite
Nguyễn, T. H., & Nguyễn, N. Q. (2021). Survey of bleeding incidence in patients with atrial fibrillation receiving anticoagulant treatment at Bach Mai hospital. Viet Nam Journal of Traditional Medicine and Pharmacy, 1(Dacbiet), 109-113. https://doi.org/10.60117/vjmap.v1iDacbiet.188

Survey of bleeding incidence in patients with atrial fibrillation receiving anticoagulant treatment at Bach Mai hospital

Thị Hoa Nguyễn, Ngọc Quang Nguyễn

Main Article Content

Abstract

Objectives: To investigate bleeding events in patients with atrial fibrillation treated with anticoagulants at the Department of Examination and Treatment on Demand - Bach Mai Hospital.


Subjects and methods: The study was designed according to the descriptive method of research on 171 patients with atrial fibrillation who came for examination and treatment at the Medical Examination Department as requested by Bach Mai Hospital during the period from 8/2019 - 8/2020.


Results: Patients with atrial fibrillation taking anticoagulants had mild bleeding signs (87%), with no difference in the group of drugs used. Subjects with artificial valve disease, embolism increases the risk of bleeding.

Article Details

Keywords

Incidence in patients, Bach Mai hospital

References

1. Connolly SJ, et al, (2009), “RE – LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation”, N Engl J Med 2009; 361: 1139 – 1151.
2. Hayano J, Yamasaki F, Sakata Set, et al, (1997); “Spectral Characteristics ofVentricular Response to Atrial Fibrillation”; Am J Physiol; 273; (6); 2811-6.
3. Hilgard J, Ezri MD, Denes P, (1985); "Significance of ventricularpauses of three seconds or more detected on twenty-four-hour Holter recordings”; Am J Cardiol, 55; (8); 1005-8.
4. Psaty BM, Manolio TA, Kuller LH et al, (1997); “Incidence of and risk factors for atrial fibrillation in older adults”; Circulation; 96; (7); 2455-61
5. Rienstra M, Van Veldhuisen DJ, Hagens VE et al, (2005); “Gender-Related Differences in Rhythm Control Treatment in Persistent Atrial Fibrillation: Data of the Rate Control Versus Electrical Cardioversion (Race) Study”, JAm Coll Cardiol; 46; (7); 1298-306.
6. Saba MM et al., (2005), “Long-term mortality in patients with pauses inventricular electrical activity”; Pacing Clin Bectrophysỉoỉ; 28; (11); 1203-7.
7. Savelieva I., et al, (2001); “Quality of life in patients with silent atrialfibrillation. Heart”; Heart, 85;(2);216-7.
8. Serrano CM, Hernandez-Madrid A, (2009); “Atrial Fibrillation: Is itan Epidemic?”; Rev Esp Cardiol; 62; (1); 10-4.